ALNY
Price
$321.94
Change
-$3.06 (-0.94%)
Updated
Jun 25 closing price
Capitalization
41.98B
35 days until earnings call
ATHA
Price
$0.31
Change
+$0.01 (+3.33%)
Updated
Jun 25 closing price
Capitalization
12.18M
53 days until earnings call
Interact to see
Advertisement

ALNY vs ATHA

Header iconALNY vs ATHA Comparison
Open Charts ALNY vs ATHABanner chart's image
Alnylam Pharmaceuticals
Price$321.94
Change-$3.06 (-0.94%)
Volume$632.57K
Capitalization41.98B
Athira Pharma
Price$0.31
Change+$0.01 (+3.33%)
Volume$196.04K
Capitalization12.18M
ALNY vs ATHA Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. ATHA commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongBuy and ATHA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (ALNY: $321.94 vs. ATHA: $0.31)
Brand notoriety: ALNY and ATHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 70% vs. ATHA: 28%
Market capitalization -- ALNY: $41.98B vs. ATHA: $12.18M
ALNY [@Biotechnology] is valued at $41.98B. ATHA’s [@Biotechnology] market capitalization is $12.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileATHA’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • ATHA’s FA Score: 1 green, 4 red.
According to our system of comparison, ALNY is a better buy in the long-term than ATHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while ATHA’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 4 bearish.
  • ATHA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both ALNY and ATHA are a good buy in the short-term.

Price Growth

ALNY (@Biotechnology) experienced а +3.08% price change this week, while ATHA (@Biotechnology) price change was +0.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +31.79%, and the average quarterly price growth was +15.79%.

Reported Earning Dates

ALNY is expected to report earnings on Jul 31, 2025.

ATHA is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($42B) has a higher market cap than ATHA($12.2M). ALNY YTD gains are higher at: 36.815 vs. ATHA (-46.821). ATHA has higher annual earnings (EBITDA): -77.65M vs. ALNY (-152.58M). ALNY has more cash in the bank: 2.63B vs. ATHA (36.7M). ATHA has less debt than ALNY: ATHA (1.12M) vs ALNY (1.3B). ALNY has higher revenues than ATHA: ALNY (2.35B) vs ATHA (0).
ALNYATHAALNY / ATHA
Capitalization42B12.2M344,262%
EBITDA-152.58M-77.65M196%
Gain YTD36.815-46.821-79%
P/E RatioN/AN/A-
Revenue2.35B0-
Total Cash2.63B36.7M7,172%
Total Debt1.3B1.12M116,562%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
20
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYATHA
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 15 days ago
66%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCR0.550.01
+1.89%
Heartcore Enterprises
DB29.28-0.03
-0.10%
Deutsche Bank Aktiengesellschaft
LPL3.55-0.02
-0.56%
LG Display Co Ltd
NCDL16.30-0.11
-0.67%
Nuveen Churchill Direct Lending Corp
QSG9.34-0.71
-7.06%
QuantaSing Group Limited

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
-0.94%
IONS - ALNY
53%
Loosely correlated
+0.91%
ARGX - ALNY
47%
Loosely correlated
-1.33%
SGMO - ALNY
42%
Loosely correlated
+13.27%
VXRT - ALNY
40%
Loosely correlated
-3.93%
ALLO - ALNY
37%
Loosely correlated
-0.80%
More

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with OGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then OGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+4.70%
OGEN - ATHA
38%
Loosely correlated
-4.16%
ALNY - ATHA
35%
Loosely correlated
-0.94%
PCVX - ATHA
33%
Poorly correlated
-2.93%
MNKD - ATHA
32%
Poorly correlated
-3.51%
SNGX - ATHA
31%
Poorly correlated
+1.50%
More